C

Cytokinetics

CYTK

57.910
USD
-1.15
(-1.95%)
Market Closed
Volume
30,502
EPS
0
Div Yield
0
P/E
-10
Market Cap
6,464,217,215
Related Instruments
C
CLLS
-0.11000
(-4.89%)
2.14000 USD
C
CRBP
-0.500
(-0.84%)
59.160 USD
F
FOLD
-0.140
(-1.36%)
10.180 USD
G
GLPG
0.270
(1.01%)
26.970 USD
M
MRTX
0
(0%)
0.000000 USD
NVS
0.650
(0.58%)
112.100 USD
R
RETA
0
(0%)
0.000000 USD
S
SRPT
1.650
(1.16%)
144.000 USD
V
VYGR
-0.59000
(-6.37%)
8.67000 USD
News

Title: Cytokinetics

Sector: Healthcare
Industry: Biotechnology
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.